Program Co-leaders
Program Goal
To reduce morbidity and mortality of cancer based on fundamental understanding of cancer biology.
Program Aims
- AIM 1: Identify and validate targets that mediate innate and acquired resistance to anticancer therapies.
To improve the understanding of how cancers resist targeted therapies or develop resistance during recurrence. - AIM 2: Target mechanisms that are deregulated in cancer and promote metastasis.
To define and therapeutically target mechanisms including cell signaling pathways necessary for cancer spread and recurrence. - AIM 3: Develop strategies to improve diagnosis, inform treatment, and evaluate treatment response.
To develop and apply new technologies to advance cancer detection and evaluate tumor response for precision medicine.
Visit the University of Maryland School of Medicine Institute for Genome Sciences (IGS) .